BIO-key International, Inc.
BKYI
$0.71
-$0.03-3.98%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.32M | 6.91M | 6.36M | 6.93M | 7.29M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.32M | 6.91M | 6.36M | 6.93M | 7.29M |
| Cost of Revenue | 1.36M | 1.47M | 1.27M | 1.29M | 2.95M |
| Gross Profit | 4.95M | 5.44M | 5.09M | 5.64M | 4.34M |
| SG&A Expenses | 6.31M | 6.51M | 6.78M | 7.19M | 7.51M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.20M | 10.48M | 10.50M | 10.94M | 12.76M |
| Operating Income | -3.88M | -3.57M | -4.14M | -4.01M | -5.47M |
| Income Before Tax | -4.28M | -4.05M | -4.55M | -4.32M | -5.57M |
| Income Tax Expenses | -23.00K | -23.00K | -23.00K | -23.00K | -276.80K |
| Earnings from Continuing Operations | -4.25 | -4.03 | -4.53 | -4.30 | -5.29 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.25M | -4.03M | -4.53M | -4.30M | -5.29M |
| EBIT | -3.88M | -3.57M | -4.14M | -4.01M | -5.47M |
| EBITDA | -3.51M | -3.18M | -3.75M | -3.61M | -4.99M |
| EPS Basic | -0.96 | -1.20 | -2.01 | -2.17 | -6.17 |
| Normalized Basic EPS | -0.60 | -0.76 | -1.26 | -1.36 | -4.36 |
| EPS Diluted | -0.96 | -1.20 | -2.01 | -2.17 | -6.17 |
| Normalized Diluted EPS | -0.60 | -0.76 | -1.26 | -1.36 | -4.36 |
| Average Basic Shares Outstanding | 20.14M | 15.45M | 11.29M | 8.20M | 5.70M |
| Average Diluted Shares Outstanding | 20.14M | 15.45M | 11.29M | 8.20M | 5.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |